ORGANIZATION AND BUSINESS (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($) Product Facility	Dec. 31, 2023 USD ($)
Organization and Business [Abstract]
Number of plasma collection facilities under approval and development | Facility	10
Number of FDA approved product | Product	3
Working capital	$ 273,300
Cash and cash equivalents	86,707	$ 51,352
Accounts receivable	50,140	27,421
Inventories	171,801	172,906
Current liabilities	$ 44,891	$ 49,806